Among them, hsa-miR-543, as well as ZNRD1, GPR68, CAT, FUT3, ANPEP, and CDK1 genes, were proposed as crucial players in osteosarcoma chemoresistance, and hence they could represent potential therapeutic targets for osteosarcoma [84] (Figure 3). This evidence concerns the gene CAT and osteosarcoma.